more

Vertex Pharmaceuticals (VRTX)

(Delayed Data from NSDQ)

$483.00 USD

-15.73 (-3.15%)

Updated Oct 18, 2024 04:00 PM ET

After-Market: $483.08 +0.08 (0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.10%
2	Buy	17.80%
3	Hold	9.50%
4	Sell	2.70%
5	Strong Sell	2.70%
S&P	500	11.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth A Momentum F VGM

Industry Rank:

Top 35% (87 out of 250)

Industry: Medical - Biomedical and Genetics

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Bull of the Day: Vertex Pharma (VRTX)

by Kevin Cook Published on May 19,2020

While COVID-19 interrupts clinical trials, the champ of cystic fibrosis is about to repeat another year of 37% revenue growth

Surging Earnings Estimates Signal Good News for Vertex Pharmaceuticals (VRTX)

by Zacks Equity Research Published on May 18,2020

Vertex Pharmaceuticals (VRTX) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.

VRTXNegative Net Change

Wall Street to Rally as Powell Talks Recovery: 5 Big Winners

by Tirthankar Chakraborty Published on May 18,2020

Wall Street poised to gain after Powell expressed confidence that the U.S. economy will recover beginning summer.

Buy These 4 Stocks With Attractive Interest Coverage Ratio

by Sumit Singh Published on May 18,2020

Interest Coverage Ratio is used to determine how effectively a company can pay the interest charges on its debt.

3 Reasons Growth Investors Will Love Vertex (VRTX)

by Zacks Equity Research Published on May 14,2020

Vertex (VRTX) is well positioned to outperform the market, as it exhibits above-average growth in financials.

VRTXNegative Net Change

Has Vertex Pharmaceuticals (VRTX) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research Published on May 11,2020

Is (VRTX) Outperforming Other Medical Stocks This Year?

VRTXNegative Net Change

Wall Street Resilient to Crisis-Era Jobless Rate: 5 Picks

by Tirthankar Chakraborty Published on May 11,2020

Stocks finished last week in the green despite massive job losses as the market expects a sharp but short recession.

Moderna (MRNA) Q1 Loss Narrows, Revenues Miss Estimates

by Zacks Equity Research Published on May 08,2020

Moderna (MRNA) reports narrower-than-expected first-quarter loss. The company plans to initiate phase II study on coronavirus vaccine soon.

Zacks.com featured highlights include: Logitech International, MACOM Technology Solutions, Murphy USA, Vertex Pharmaceuticals and The Clorox Company

by Zacks Equity Research Published on May 08,2020

Zacks.com featured highlights include: Logitech International, MACOM Technology Solutions, Murphy USA, Vertex Pharmaceuticals and The Clorox Company

4 Best Stocks to Buy for Stellar Earnings Growth

by Tirthankar Chakraborty Published on May 08,2020

We have selected four solid stocks that have striking earnings growth and positive estimate revisions.

Horizon Therapeutics' (HZNP) Q1 Earnings Beat Estimates

by Zacks Equity Research Published on May 07,2020

Horizon Therapeutics (HZNP) beat on earnings and sales in the first quarter of 2020. The company lifts net sales guidance for the full year.

Zacks.com featured highlights include: Activision Blizzard, Guardant Health, Vertex Pharmaceuticals, Aphria and Shopify

by Zacks Equity Research Published on May 07,2020

Zacks.com featured highlights include: Activision Blizzard, Guardant Health, Vertex Pharmaceuticals, Aphria and Shopify

5 Stocks That Look Appealing on Relative Price Strength

by Nilanjan Choudhury Published on May 07,2020

Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.

3 Market-Beating Growth Stocks

by James Giaquinto Published on May 07,2020

3 Market-Beating Growth Stocks

earnings

Can Vertex (VRTX) Run Higher on Rising Earnings Estimates?

by Zacks Equity Research Published on May 06,2020

Vertex (VRTX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

VRTXNegative Net Change

Zacks.com featured highlights include: Vertex Pharmaceuticals, Alibaba, Amedisys and Fabrinet

by Zacks Equity Research Published on May 06,2020

Zacks.com featured highlights include: Vertex Pharmaceuticals, Alibaba, Amedisys and Fabrinet

Zacks.com featured highlights include: Cogent Communications, Murphy USA, Vertex Pharmaceuticals and B2Gold

by Zacks Equity Research Published on May 06,2020

Zacks.com featured highlights include: Cogent Communications, Murphy USA, Vertex Pharmaceuticals and B2Gold

5 Top-Ranked Stocks to Tap Earnings Beat Potential

by Sanghamitra Saha Published on May 06,2020

Forget earnings growth, bet on these top-ranked stocks to cash in on earnings beat.

earnings

Scoop Up These 4 Stocks With Amazing Interest Coverage Ratio

by Sumit Singh Published on May 05,2020

Interest Coverage Ratio suggests how many times the interest could be paid from earnings and gauges the margin of safety a firm has for paying interest.

4 Momentum Picks Screened on Driehaus Strategy

by Nitish Marwah Published on May 05,2020

Driehaus strategy is perfect for investors who have the propensity to take high levels of risk.

Vertex (VRTX) Q1 Earnings Beat, Trikafta Drives CF Revenues

by Zacks Equity Research Published on April 30,2020

Vertex (VRTX) rides high on earnings and revenue beat in Q1.The company raises its revenue guidance on the strong uptake of its newest CF drug, Trikafta. Shares rise in after-hours trading.

BioMarin (BMRN) Beats on Q1 Earnings, Lowers Sales View

by Zacks Equity Research Published on April 30,2020

BioMarin (BMRN) beats estimates for both earnings and sales in the first quarter. It lowers its total revenue outlook for the year due to the potential impact of coronavirus outbreak.

biotechs